Podcast 20 Sep 2024
Estonia’s biobank: Is this the first large-scale personalized medicine initiative?
Estonia is working on becoming the first country to implement personalized health at scale through the Estonian National Biobank.
genomics
- Latest Posts
In Depth 29 Sep 2023
Illumina: DNA giant in troubled waters
A botched acquisition deal and unrest among company investors amid plummeting stocks have plagued Illumina, which was once part of the biotech big leagues that dominated the field of gene sequencing. Now, in fear of losing its ground to other players in the space, it has received a European Commission order to divest Grail, and […]
Opinion 20 Sep 2023
The next frontier in genomic technologies for rare diseases
By Neil Ward, VP and General Manager at PacBio EMEA It’s been 40 years since the passage of the Orphan Drug Act, which catalyzed the development of hundreds of therapies for rare diseases, with more than half approved in the last decade. More recently in 2022, the U.K. government launched a Rare Diseases Action Plan […]
Sub-$100 genome sequencing the highlight of Complete Genomics’ 18th anniversary milestone
News and Trends 12 May 2023
5 highlights at first Genomics and Precision Medicine Expo
Genomics and Precision Medicine Expo – taking place on May 23 and 24 2023 at ExCeL London – has announced its top 5 highlights for this year’s inaugural conference. The event, which is being run in partnership with Genomics England, will explore the latest advancements and developments in genome sequencing and genomic testing, and the […]
Opinion 14 Apr 2023
20 years ago today: how genetic sequencing is changing lives since the Human Genome Project
By Dr. Radoje Drmanac, CSO of MGI and Complete Genomics Today marks the 20th anniversary of the completion of the first human genome sequence, which was mapped out on April 14, 2003. Initially a targeted effort to understand the impact of radiation on human beings, the Human Genome Project (HGP) set in motion countless advancements […]
ADVERTISEMENT
ADVERTISEMENT
News and Trends 2 Mar 2023
Genomic medicine company Chroma raises $135M
Chroma Medicine, Inc., a genomic medicine company advancing single-dose epigenetic editing therapeutics, has completed a $135 million Series B financing. The funding was led by GV (Google Ventures), with participation from additional new investors ARCH Venture Partners, DCVC Bio, Mubadala Capital, Sixth Street, and all existing investors, including Alexandria Venture Investments, Atlas Venture, Casdin Capital, […]
In Depth 1 Feb 2023
Expanding the world of biomarkers with proteogenomics
By Michael Pisano, executive vice president, proteomics, Discovery Life Sciences In oncology, characterizing genetic markers is a powerful tool, but it only tells part of the story. A burgeoning field called proteogenomics is helping uncover downstream biomarkers that represent the functional changes resulting from gene expression that will launch research and development of new, targeted […]
News and Trends 1 Feb 2023
Advancing cancer care with 3D genomics
By Oxford BioDynamics Cancer care is in urgent need of effective tests to determine the best approach for personalized medicine. Practical, new solutions exploiting the power of 3D genomics are emerging. Cancer is a vastly complex, multidimensional disease marked by the uncontrolled proliferation of cells. Many intertwined layers of biological systems give rise to the […]
News and Trends 1 Feb 2023
Cancer Genomics: Technological innovation set to fuel research breakthroughs
By Neil Ward, vice President and general manager, PacBio EMEA We’ve known for a long time that genomic sequencing can strengthen our understanding of cancer’s highly complex and variable pathology. But to date, embedding genomics into cancer research has been challenging because of limitations in sequencing technology. But with recent innovations, this is changing. Genomic […]
News and Trends 19 Jan 2023
Hundreds of genetic discoveries from FinnGen study
New results from the FinnGen research consortium include previously unknown genetic risk factors for many debilitating diseases. These findings have potential to facilitate the development of new therapies. Since initiation in 2017, the FinnGen study has developed into one of the world’s leading biobank-based genomic research projects. Currently, FinnGen is completing the construction of a […]
News and Trends 11 Jan 2023
Lifesciences and biotech in 2023
A Q&A with Bill Coyle, principal, ZS. ZS is a management consulting and technology firm focused on transforming global healthcare. In some ways, 2022 could be seen as a challenging year—at least financially—in biotech. Do you see those trends continuing? Although we see overall sentiments to invest in biotech turning positive in 2023 after a […]
ADVERTISEMENT